56 related articles for article (PubMed ID: 4071064)
1. Studies on the purification and characteristics of histidine-rich glycoprotein.
Sakuragawa N; Niwa M; Yamagishi R
Semin Thromb Hemost; 1985 Oct; 11(4):384-6. PubMed ID: 4071064
[TBL] [Abstract][Full Text] [Related]
2. Interaction between histidine-rich glycoprotein and platelet factor 4 with dermatan sulfate and low-molecular-weight dermatan sulfate.
Cella G; Boeri G; Saggiorato G; Paolini R; Luzzatto G; Terribile VI
Angiology; 1992 Jan; 43(1):59-62. PubMed ID: 1554154
[TBL] [Abstract][Full Text] [Related]
3. Activation of heparin cofactor II by heparin and dermatan sulfate.
Tollefsen DM
Nouv Rev Fr Hematol (1978); 1984; 26(4):233-7. PubMed ID: 6548014
[TBL] [Abstract][Full Text] [Related]
4. Modulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4.
Tollefsen DM; Pestka CA
J Clin Invest; 1985 Feb; 75(2):496-501. PubMed ID: 3838317
[TBL] [Abstract][Full Text] [Related]
5. Regulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavage.
Poon IK; Olsson AK; Hulett MD; Parish CR
Biochem J; 2009 Oct; 424(1):27-37. PubMed ID: 19712047
[TBL] [Abstract][Full Text] [Related]
6. Histidine-rich glycoprotein plus zinc reverses growth inhibition of vascular smooth muscle cells by heparin.
Mori S; Shinohata R; Renbutsu M; Takahashi HK; Fang YI; Yamaoka K; Okamoto M; Yamamoto I; Nishibori M
Cell Tissue Res; 2003 Jun; 312(3):353-9. PubMed ID: 12764609
[TBL] [Abstract][Full Text] [Related]
7. Effect of oversulfated dermatan sulfate derivatives on platelet aggregation.
Maaroufi RM; Giordano P; Triadou P; Tapon-Bretaudière J; Dautzenberg MD; Fischer AM
Thromb Res; 2007; 120(4):615-21. PubMed ID: 17222891
[TBL] [Abstract][Full Text] [Related]
8. Modulation of protein C inhibitor activity by histidine-rich glycoprotein and platelet factor 4: role of zinc and calcium ions in the heparin-neutralizing ability of histidine-rich glycoprotein.
Kazama Y; Koide T
Thromb Haemost; 1992 Jan; 67(1):50-5. PubMed ID: 1319617
[TBL] [Abstract][Full Text] [Related]
9. Hereditary increase of plasma histidine-rich glycoprotein associated with abnormal heparin binding (HRG Eindhoven).
Hoffmann JJ; Hennis BC; Kluft C; Vijgen M
Thromb Haemost; 1993 Dec; 70(6):894-9. PubMed ID: 8165607
[TBL] [Abstract][Full Text] [Related]
10. Histidine-rich glycoprotein inhibited high mobility group box 1 in complex with heparin-induced angiogenesis in matrigel plug assay.
Wake H; Mori S; Liu K; Takahashi HK; Nishibori M
Eur J Pharmacol; 2009 Nov; 623(1-3):89-95. PubMed ID: 19786011
[TBL] [Abstract][Full Text] [Related]
11. New method for purifying histidine-rich glycoprotein from human plasma redefines its functional properties.
Patel KK; Poon IK; Talbo GH; Perugini MA; Taylor NL; Ralph TJ; Hoogenraad NJ; Hulett MD
IUBMB Life; 2013 Jun; 65(6):550-63. PubMed ID: 23576524
[TBL] [Abstract][Full Text] [Related]
12. Histidine-rich glycoprotein inhibits the antithrombin activity of heparin cofactor II in the presence of heparin or dermatan sulfate.
Niwa M; Yamagishi R; Kondo S; Sakuragawa N; Koide T
Thromb Res; 1985 Jan; 37(1):237-40. PubMed ID: 3838602
[No Abstract] [Full Text] [Related]
13. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA
J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790
[TBL] [Abstract][Full Text] [Related]
14. [The second cofactor of heparin].
Sie P
Ann Biol Clin (Paris); 1987; 45(2):181-3. PubMed ID: 3619144
[TBL] [Abstract][Full Text] [Related]
15. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN
Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
Ofosu FA
Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
[TBL] [Abstract][Full Text] [Related]
17. Heparin cofactor II and other endogenous factors in the mediation of the antithrombotic and anticoagulant effects of heparin and dermatan sulfate.
Ofosu FA; Fernandez F; Gauthier D; Buchanan MR
Semin Thromb Hemost; 1985 Apr; 11(2):133-7. PubMed ID: 3898370
[No Abstract] [Full Text] [Related]
18. Further characterization of the interaction of histidine-rich glycoprotein with heparin: evidence for the binding of two molecules of histidine-rich glycoprotein by high molecular weight heparin and for the involvement of histidine residues in heparin binding.
Burch MK; Blackburn MN; Morgan WT
Biochemistry; 1987 Nov; 26(23):7477-82. PubMed ID: 3427089
[TBL] [Abstract][Full Text] [Related]
19. A simple method to measure dermatan sulfate at sub-microgram concentrations in plasma.
Dupouy D; Sié P; Dol F; Boneu B
Thromb Haemost; 1988 Oct; 60(2):236-9. PubMed ID: 3217919
[TBL] [Abstract][Full Text] [Related]
20. The additive effect of low molecular weight heparins on thrombin inhibition by dermatan sulfate.
Cosmi B; Agnelli G; Young E; Hirsh J; Weitz J
Thromb Haemost; 1993 Sep; 70(3):443-7. PubMed ID: 8259546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
